Log In
Print this Print this

diepalrestat choline (BNV-222)

  Manage Alerts
Collapse Summary General Information
Company BioNevia LLC
DescriptionExtended-release diepalrestat, a cocrystal of epalrestat, a reversible aldose reductase inhibitor
Molecular Target Aldose reductase
Mechanism of ActionAldose reductase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationNeuropathy
Indication DetailsTreat diabetic peripheral neuropathy (DPN)
Regulatory Designation
PartnerNeuroMax Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today